Access & Reimbursement Strategy
Define the access ambition, priority pathways and strategic choices that balance patient value, system realities and business objectives.
MARKET ACCESS STRATEGY · MEXICO & LATIN AMERICA
Access is not a final step.
It is a strategic choice.
We connect value, evidence, stakeholders, commercial choices and organizational activation to build credible access paths across Mexico and Latin America.
01 / THE CHALLENGE
A technically sound access plan can still fail in the organization.
Market access creates value when evidence, stakeholder needs, affordability, commercial priorities and execution are designed as one system—not as disconnected workstreams.
02 / WHERE WE HELP
From access ambition to an executable path.
Focused support at the decisions where strategic coherence matters most.
Value Proposition & Evidence Translation
Turn clinical, economic and real-world evidence into a differentiated value story built for the stakeholders who shape access.
Stakeholder & Institutional Strategy
Map influence, needs and decision dynamics across public and private systems to prioritize purposeful engagement.
Launch & Portfolio Access Planning
Integrate access early into launch, lifecycle and portfolio choices so critical dependencies are addressed before they become barriers.
Access Operating Model & Change Management
Align roles, governance, capabilities and behaviors so the organization can execute the strategy—not simply approve it.
03 / CRITICAL MOMENTS
When access becomes a business-critical decision.
A launch is approaching.
You need one integrated access, evidence and stakeholder agenda before major commitments are locked.
An asset is not moving.
The technical plan exists, but the real barrier—or the organizational response to it—remains unclear.
The portfolio is expanding.
You need to compare access potential, sequence investments and focus resources across markets or indications.
The access model must evolve.
New system, customer or competitive realities require different capabilities, governance and ways of working.
04 / OUR APPROACH
Strategy and change. Designed together.
Frame
Clarify the decision, ambition, constraints and definition of access success.
Map
Decode the system, stakeholders, evidence, economics and organizational readiness.
Design
Build the strategic path, value narrative and prioritized access choices.
Mobilize
Align leaders, functions, governance and capabilities around the chosen path.
Activate
Translate strategy into owners, first moves, adoption measures and learning loops.
Change methods adapted to context: Kotter · Prosci ADKAR · Agile
05 / TANGIBLE OUTPUTS
Useful in the room. Actionable after it.
Every engagement is shaped around the decision at hand. Typical outputs include:
- 01Access landscape and barrier map
- 02Stakeholder and influence map
- 03Differentiated value proposition
- 04Prioritized access roadmap
- 05Governance, roles and decision rights
- 06Change and adoption plan
06 / WHY ACCESSLERATE
Operator judgment. External clarity.
Accesslerate brings the objectivity of an external advisor and the practical judgment of a healthcare operator. The work is led directly by Yuriko Tovar, drawing on 20+ years across market access, growth, commercial transformation and organizational change in Mexico and Latin America.
Selected operator experience
20+Years across healthcare
1 yearAccess milestone delivered early
5Healthcare sectors
Results shown reflect Yuriko Tovar’s prior executive roles.
07 / FREQUENTLY ASKED QUESTIONS
Questions healthcare leaders ask us.
01What does Market Access consulting include?+
It can include access and reimbursement strategy, value proposition, evidence translation, stakeholder mapping, launch planning, operating-model design and change activation. The scope is built around the decision—not a fixed methodology.
02When should Market Access strategy begin?+
Ideally before launch assumptions and investments are locked. Early integration makes it possible to shape evidence, value, stakeholder and commercial choices together. We also help when an existing asset or model needs to be reset.
03Do you work across public and private health systems?+
Yes. We shape the engagement to the relevant public, social-security, institutional and private pathways in Mexico and across Latin America.
04Can you support MedTech, diagnostics and other healthcare businesses?+
Yes. Our perspective spans Pharma, Biotech, Consumer Health, MedTech, Diagnostics and Health Services, with the access model adapted to each category.
05How does Change Management fit into Market Access?+
A strategy only creates value when leaders and teams adopt new priorities, roles and behaviors. We design alignment, governance, capability building and adoption into the access roadmap from the start.
08 / START A CONVERSATION
Bring us the access question that matters most.
In a focused 30-minute conversation, we will explore the context, what is at stake and whether Accesslerate is the right partner.